Results 191 to 200 of about 3,204,619 (291)

Limited effectiveness of radioiodine therapy for residual cervical lymph node metastases in radioiodine-naïve papillary thyroid cancer. [PDF]

Front Endocrinol (Lausanne)
Ilgan S, Emer MÖ, Taneri F, Aygenç E, Özbaş S, Akın M, Öztürk E, Bilezikçi B, Gulec SA.   +8 more
europepmc   +1 more source

Interactions Between E3 Ubiquitin Ligases and Deubiquitinases in AKT Regulation: Implications in Skeletal Muscle Homeostasis

Cell Biochemistry and Function, Volume 44, Issue 9, September 2026.
ABSTRACT AKT (protein kinase B, PKB) coordinates the balance between anabolic and catabolic signaling in skeletal muscle through distinct ubiquitin chain types. Some E3 ubiquitin ligases (E3s) and deubiquitinases (DUBs) form stable binary complexes via non‐catalytic interfaces, adding a regulatory layer unavailable to either enzyme alone.
Rajesh Dabur
wiley   +1 more source

De-escalation implementation in low-risk papillary thyroid cancer: a nationwide survey. [PDF]

Endocr Connect
Effraimidis G, Sazakli E, Karapanou O, Saltiki K, Michalaki MA.   +4 more
europepmc   +1 more source

Asymptomatic Medullary Thyroid Carcinoma With Isolated Carcinoembryonic Antigen Elevation in a Patient With Chronic Kidney Disease: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Medullary thyroid carcinoma (MTC) is rare and typically presents with a palpable nodule. We report a 64‐year‐old asymptomatic woman with chronic kidney disease (CKD) diagnosed with MTC after incidental procalcitonin elevation on routine labs, highlighting procalcitonin as an atypical clue and the need to distinguish tumor‐related from CKD ...
Orhan Altınyüzük, Bartu Ediz, Serkan Feyyaz Yalın, Ergün Parmaksız   +3 more
wiley   +1 more source

Postoperative serum oxidative stress measures in women with papillary thyroid cancer. [PDF]

Front Endocrinol (Lausanne)
Buczyńska-Backiel A, Sidorkiewicz I, Kościuszko M, Siewko K, Popławska-Kita A, Rusak M, Adamski M, Dzięcioł-Anikiej Z, Dzięcioł J, Szymczuk J, Hady HR, Myśliwiec P, Krętowski AJ, Adamska A.   +13 more
europepmc   +1 more source

Interobserver variation among cytopathologists in the evaluation of oncocytic cell‐predominant thyroid FNA cytology: A validation study of 173 cases with surgical follow‐up and correlation with molecular testing

Cancer Cytopathology, Volume 134, Issue 9, September 2026.
Abstract Background Interpretation of oncocytic cell‐predominant cytologies (OCP) is very challenging as a majority of those cases are diagnosed as indeterminate, including atypia of undetermined significance (AUS) and follicular neoplasm (FN). The authors previously reported a combination of a four‐risk factor model highly predictive of neoplasia and ...
Tarik M. Elsheikh, Erika E. Doxtader, Marko Golusin, Juan Xing, James F. Bena, Lame Balikani   +5 more
wiley   +1 more source

Dynamic effects of radioactive iodine therapy on gut microbiota and metabolites in patients with papillary thyroid cancer. [PDF]

Microbiol Spectr
Cao Y, Zhang X, Tan J, Wang Y, Guo Q, Gao Y, Chen J, Chen Y, Tong K, Fu Z, Ma L, Wu C, Li F, Pang X, Liu M, Zhu H.   +15 more
europepmc   +1 more source

Comprehensive In Silico Analysis Identifies MSTO1 and LIG1 as Candidate Biomarkers With Diagnostic and Prognostic Relevance in Hepatocellular Carcinoma

Cancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and remains a major cause of cancer‐related mortality worldwide. Its poor clinical outcomes are largely attributed to late‐stage diagnosis and the limited accuracy of currently available diagnostic and prognostic biomarkers.
Jana Hamad, Hussein Fayyad‐Kazan, Fadi Abdel‐Sater   +2 more
wiley   +1 more source

The anticancer properties of dexmedetomidine in papillary thyroid cancer and its underlying mechanisms. [PDF]

Sci Rep
Sun Y, Yan X, Zhang Y, Luo Y.
europepmc   +1 more source

Prognostic Factor Analysis for Risk‐Stratified Papillary Thyroid Carcinoma and Nomogram Development for Predicting Structural Incomplete Response to Radioactive Iodine Therapy in Intermediate‐Risk Patients

Cancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Structural incomplete response (SIR) after radioactive iodine (RAI) therapy indicates persistent or recurrent structural disease and has important implications for the long‐term management of patients with papillary thyroid carcinoma (PTC).
Yamin Li, Zhaohui He, Min Zhao, Bin Zhang   +3 more
wiley   +1 more source